Related Experiment Videos

Prognostic factors for breast cancer: have they met their promise?

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|May 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study.

Breast cancer research and treatment·2017

Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up.

Breast cancer research and treatment·2012

Systemic mirnas as potential biomarkers for malignancy.

International journal of cancer·2012

A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone.

Molecular endocrinology (Baltimore, Md.)·2011

DNA repair signature is associated with anthracycline response in triple negative breast cancer patients.

Breast cancer research and treatment·2010

See all related articles